Christopher W. Ryan

9.5k citations
165 papers · 5.9k indexed · 2 hit papers · h-index 38

Impact in

    • Gastrointestinal Tumor Research and Treatment
    • Sarcoma Diagnosis and Treatment
    • Renal cell carcinoma treatment
    • Prostate Cancer Treatment and Research
    • Gastric Cancer Management and Outcomes

Papers in

    • Renal cell carcinoma treatment 37
    • Sarcoma Diagnosis and Treatment 32
    • Prostate Cancer Treatment and Research 30
    • Vascular Tumors and Angiosarcomas 11
    • Cancer Treatment and Pharmacology 9

Christopher W. Ryan

157 papers receiving 5.8k citations

Hit Papers

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033 2008 · 768 citations
7682008202620142020250500750

Peers

Christopher W. Ryan
Comparison fields: 5 of 132
  • Gastroenterology 1.2k
  • Pulmonary and Respiratory Medicine 3.7k
  • Oncology 1.9k
  • Cancer Research 975
  • Pathology and Forensic Medicine 516
Replace Carol J. Swallow with:
Carol J. Swallow Canada
Paul M. Schneider Germany
Giovanni Grignani Italy
Claus Langer Germany
Hidetaka Yamamoto Japan
Bruce G. Robinson Australia
Sumiya Ishigami Japan
Penella J. Woll United Kingdom
Maria A. Pantaleo Italy
Jungnam Joo South Korea
Christopher W. Ryan relative to Carol J. Swallow Canada Carol J. Swallow's profile →
Citations per field
00.5×
Carol J. Swallow · 1×
Citations per year

Countries citing papers authored by Christopher W. Ryan

Since Specialization
Citations

This map shows the geographic impact of Christopher W. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Ryan more than expected).

Fields of papers citing papers by Christopher W. Ryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher W. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Ryan. The network helps show where Christopher W. Ryan may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher W. Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher W. Ryan Line = papers co-authored together Christopher W. Ryan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20251
4 20242
5 20240
6 20244
7 202315
8 202321
9 20231
10 20223
11 20222
12 202118
13 20218
14 2019174
15 20161
16 200641
17 200531
18 20054
19 20048
20 200393

About Christopher W. Ryan

Christopher W. Ryan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Gastroenterology and Genetics, having authored 165 papers that have together received 5.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (37 papers), Sarcoma Diagnosis and Treatment (32 papers), Prostate Cancer Treatment and Research (30 papers), Cancer Genomics and Diagnostics (23 papers), Renal and related cancers (19 papers), Wildlife Ecology and Conservation (11 papers), Vascular Tumors and Angiosarcomas (11 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Gastroenterology (1.2k citations), Pulmonary and Respiratory Medicine (3.7k citations), Oncology (1.9k citations), Cancer Research (975 citations) and Pathology and Forensic Medicine (516 citations). Christopher W. Ryan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Tomasz M. Beer, George D. Demetri, Margaret von Mehren, Cathryn Rankin, Ernest C. Borden, Charles D. Blanke, Walter M. Stadler, Vivien Bramwell, Michael C. Heinrich and Robert S. Benjamin. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, The Journal of Urology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026